Mr. Sanjeev Rai Mehta
chairman
pharma industry
Ind-Swift
India
Biography
stablished in 1995 Ind-Swift has fast evolved towards a business model that is focused on deep-rooted domestic presence and leveraged on high-value mature regulated markets along with considerable growth in emerging markets:With manufacturing sites at 6 different locations across India and an independent State-of-the-Art R&D Centre, the Group has embarked upon a journey to establish itself as reliable partner in the Global Pharmaceutical Industry. In house capabilities for Development of APIs, Finished Dosage forms, Non-Infringing Process & World Class facilities for Contract Manufacturing are the inherent strengths.
Research Interest
Our current R&D projects include Crams for API Development Medicinal Chemistry development for various discovery projects Custom synthesis of various novel intermediates & specialty chemicals
